Metabolomics as a Tool for Discovery of Biomarkers of Autism Spectrum Disorder in the Blood Plasma of Children

@inproceedings{West2014MetabolomicsAA,
  title={Metabolomics as a Tool for Discovery of Biomarkers of Autism Spectrum Disorder in the Blood Plasma of Children},
  author={Paul R. West and David G. Amaral and Preeti Bais and Alan M Smith and Laura A. Egnash and M. Elizabeth Ross and Jessica A. Palmer and Burr R. Fontaine and Kevin R. Conard and Blythe A Corbett and Gabriela Gebrin Cezar and Elizabeth L. R. Donley and Robert E. Burrier},
  booktitle={PloS one},
  year={2014}
}
BACKGROUND The diagnosis of autism spectrum disorder (ASD) at the earliest age possible is important for initiating optimally effective intervention. In the United States the average age of diagnosis is 4 years. Identifying metabolic biomarker signatures of ASD from blood samples offers an opportunity for development of diagnostic tests for detection of ASD at an early age. OBJECTIVES To discover metabolic features present in plasma samples that can discriminate children with ASD from… CONTINUE READING